Tafinlar
Brand Name: Tafinlar
Generic Name: Dabrafenib (As Mesilate)
Expiring Soon
Registration Number
DR-XY44999
Dosage Form
Capsule
Issuance Date
December 2, 2022
Expiry Date
February 2, 2026
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength50 mg
PackagingOpaque White HDPE Plastic Bottle with Polypropylene Child resistant closure x 28's and 120's (Box of 1 bottle x 28's; Box of 1 bottle x 120's)
Classification
C
Classification
Prescription Drug (RX)
A
Application
Initial (from Monitored release)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Dabrafenib (As Mesilate)Active
Monograph: dabrafenib (as mesilate)